SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)

Market Cap	3.21B -25.3%
Revenue (ttm)	1.30B +3.4%
Net Income	261.61M -33.5%
EPS	5.85 -33.5%
Shares Out	44.59M
PE Ratio	12.31
Forward PE	n/a
Dividend	5.30 (7.31%)
Ex-Dividend Date	Jul 21, 2025

Volume	21,138
Average Volume	32,479
Open	72.30
Previous Close	72.50
Day's Range	71.90 - 72.30
52-Week Range	70.00 - 106.50
Beta	-0.10
RSI	49.20
Earnings Date	Feb 24, 2026

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulc...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1982
• Employees: 227
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1777

Financial Performance

In 2025, SYN-TECH Chem. & Pharm.'s revenue was 1.30 billion, an increase of 3.39% compared to the previous year's 1.26 billion. Earnings were 261.61 million, a decrease of -33.48%.